Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.46 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.45 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.42 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6420439 | 0.89 | CES2 (0.52) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL6416783 | 0.86 | CES2 (0.49) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL6419619 | 0.85 | POLB (0.56) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL28897506 | 0.84 | KDM4E (0.53) | ERAP1EGLN1EGLN3KDM4ECXCR2 | |
| SCHEMBL6417004 | 0.84 | CES2 (0.47) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL28451463 | 0.81 | CES2 (0.44) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL28442666 | 0.80 | GAA (0.58) | CES2CES1KDM4ENPC1RAB9A | |
| SCHEMBL6419694 | 0.79 | CNR2 (0.54) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL6419870 | 0.79 | CES2 (0.49) | CES2CES1L3MBTL1KDM4ESNCA | |
| SCHEMBL6418339 | 0.79 | KDM4E (0.51) | CES2CES1L3MBTL1KDM4ESNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110447647-B | Plant growth regulator and application thereof | 沈阳化工研究院有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-112006037-A | Plant growth regulator containing chitosan oligosaccharide and application thereof | 安徽省四达农药化工有限公司 | 2020-12-01 | — | — | CN | claimed |
| CN-111196772-B | Aroylamino isobutyryl derivative and application thereof | 沈阳化工研究院有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-110447647-B | Plant growth regulator and application thereof | 沈阳化工研究院有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-110447647-B | Plant growth regulator and application thereof | 沈阳化工研究院有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-112006037-A | Plant growth regulator containing chitosan oligosaccharide and application thereof | 安徽省四达农药化工有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-112006037-A | Plant growth regulator containing chitosan oligosaccharide and application thereof | 安徽省四达农药化工有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-111196772-A | Aroylamino isobutyryl derivative and application thereof | 沈阳化工研究院有限公司 | 2020-05-26 | — | — | CN | disclosed |
| US-6936736-B2 | Amide derivative | SUMITOMO MANUFACTURING COMPANY LIMITED (JP) | 2005-08-30 | — | — | US | disclosed |
| EP-1034783-B1 | AMIDE DERIVATIVES FOR THE TREATMENT OF RETINAL NEURODEGENERATIVE DISORDERS | SUMITOMO PHARMA (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-20020147204-A1 | Amide derivative | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED | 2002-10-10 | — | — | US | disclosed |
| US-6384033-B1 | DRUGS FOR VISION DEFECTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-1034783-A1 | AMIDE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2000-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147204-A1 | Amide derivative | ALDH1A2, NR1H2, HDAC3 | CES2 3713/4885CES1 1026/4885L3MBTL1 3197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.